BPC-157 Heals Lung Damage From Toxic Chemicals — Not Just Gut Injuries
BPC-157 attenuated lung lesions caused by intratracheal HCl alongside gastric protection, extending its cytoprotective effects to the respiratory system and demonstrating multi-organ protection.
Quick Facts
What This Study Found
BPC-157 attenuated both intratracheal HCl-induced lung lesions and associated gastric damage in rats, demonstrating cytoprotective effects extending beyond the GI tract to the respiratory system.
Key Numbers
How They Did This
Animal study in rats. Intratracheal HCl instillation to induce lung and secondary gastric lesions. BPC-157, ranitidine, omeprazole, and other anti-ulcer agents tested for both lung and gastric protection.
Why This Research Matters
Acid aspiration lung injury has no specific treatment. A peptide that protects both lungs and stomach from acid damage could benefit patients at risk of aspiration, including surgical patients and those with GERD.
The Bigger Picture
BPC-157's cytoprotection extends to the lungs — another organ system beyond its known gut effects. This broadening pattern suggests BPC-157 activates universal tissue repair mechanisms, not gut-specific ones.
What This Study Doesn't Tell Us
Rat model with acute chemical lung injury. The mechanism of lung protection was not determined. Whether BPC-157 protects against other types of lung injury is unknown.
Questions This Raises
- ?Could BPC-157 prevent aspiration pneumonitis?
- ?Does BPC-157 protect against infection-related lung damage?
- ?What mechanism mediates the lung protection?
Trust & Context
- Key Stat:
- Lungs too BPC-157 protected lungs from acid damage in addition to its known gut healing — cytoprotection that extends to the respiratory system
- Evidence Grade:
- Preliminary animal evidence extending BPC-157's protective effects to a new organ system with clear comparative drug data.
- Study Age:
- Published in 2001. BPC-157's multi-organ cytoprotection has been further documented across additional organ systems.
- Original Title:
- Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.
- Published In:
- Journal of physiology, Paris, 95(1-6), 303-8 (2001)
- Authors:
- Stancic-Rokotov, D(11), Slobodnjak, Z(3), Aralica, J(2), Aralica, G, Perovic, D, Staresinic, M, Gjurasin, M, Anic, T, Zoricic, I, Buljat, G, Prkacin, I, Sikiric, P, Seiwerth, S, Rucman, R, Petek, M, Turkovic, B, Kokic, N, Jagic, V, Boban-Blagaic, A
- Database ID:
- RPEP-00700
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Can BPC-157 protect the lungs?
In rats, yes. BPC-157 reduced lung damage from acid instillation, extending its protective effects beyond the gut to the respiratory system. This suggests its healing mechanisms work across different organ systems.
Why would a gut peptide help the lungs?
BPC-157 appears to activate universal tissue repair pathways — angiogenesis, anti-inflammation — rather than gut-specific mechanisms. This is why it can protect the lungs, skin (burns), bones, and other tissues beyond its gastric origin.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00700APA
Stancic-Rokotov, D; Slobodnjak, Z; Aralica, J; Aralica, G; Perovic, D; Staresinic, M; Gjurasin, M; Anic, T; Zoricic, I; Buljat, G; Prkacin, I; Sikiric, P; Seiwerth, S; Rucman, R; Petek, M; Turkovic, B; Kokic, N; Jagic, V; Boban-Blagaic, A. (2001). Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.. Journal of physiology, Paris, 95(1-6), 303-8.
MLA
Stancic-Rokotov, D, et al. "Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.." Journal of physiology, 2001.
RethinkPeptides
RethinkPeptides Research Database. "Lung lesions and anti-ulcer agents beneficial effect: anti-u..." RPEP-00700. Retrieved from https://rethinkpeptides.com/research/stancic-rokotov-2001-lung-lesions-and-antiulcer
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.